Objectives of webinar:
- The attendee will discuss the evolution of EEG monitoring with respect to changes in delegation of authority in the neurocritical care unit.
- Review the pharmacologic treatment options for status epilepticus (SE) and refractory status epilepticus (RSE).
- Learn who should undergo urgent EEG for possible nonconvulsive status epilepticus, including when, why and for how long.
- Review data on the management of nonconvulsive status epilepticus.
Earn 1.5 FREE credits for MD, PharmD, and Nursing!
Ceribell is focused on making electroencephalography (EEG) widely accessible, more efficient, and more cost-effective to improve the diagnosis and treatment of patients at risk for seizures. We’ve created and validated an FDA cleared instant EEG system that does not require an EEG technologist or specialist interpreter, which allows for faster results and clinical decision making. The Ceribell EEG System can be set up by any healthcare provider in 6 minutes and offers a proprietary Brain Stethoscope function that dramatically simplifies interpretation of EEG results by converting brainwaves to sound so seizures can be detected by listening. Earlier diagnosis and focused treatment for patients with seizures, including non-convulsive seizures that can only be diagnosed with EEG, can significantly lower mortality, secondary brain injury, length of stay, and risk of complications. For more information contact EEG@Ceribell.com
Release Date: October 1, 2020
Expiration Date: September 30, 2021
In support of improving patient care, this activity has been planned and implemented by Cine-Med, Gladwell CME and the Neurocritical Care Society. Cine-Med is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Cine-Med adheres to accreditation requirements regarding industry support of continuing medical education. Disclosure of the planning committee and faculty's commercial relationships will be made known at the activity. Speakers are required to openly disclose any limitations of data and/or any discussion of any off-label, experimental, or investigational uses of drugs or devices in their presentations. All Cine-Med employees, Neurocritical Care employees, and Activity Planners in control of content have indicated that they have no relevant financial relationships to disclose.